Health and Safety Stoner rat study first to closely mimic THC affinity in humans A new self-administration research model opens doors to fascinating questions that can't be explored in studies on people Nick LabaApril 7, 2020
Analysis No, cannabis isn’t recession proof, analyst says The recent COVID-19-related sales bump won't last as demand for cannabis isn't as inelastic during a recession as some think, Jerome Hass of Lightwater... Jared GnamApril 3, 2020
COVID-19 Bong for your buck: How weed could beat out alcohol as recession’s value-pick vice BDS Analytics’s CEO weighs in on the most recent round of sales data from one of the industry’s leading data firms Nick LabaApril 2, 2020
News McGill researchers find you can have a psychedelic experience without taking any drugs Study found 61 per cent of participants felt a psychedelic-like high after taking placebo pill Michelle GamageApril 2, 2020
Canada Can cannabis treat COVID-19? Toronto firm hopes clinical trial will provide answers As misinformation spreads like a virus, Cannalogue wants to conduct research to see if CBD can be used to fight the pandemic Jared GnamMarch 28, 2020
Cannabis PharmaCielo refutes short-seller claims, shares audit results The initial report provided a lengthy case as to how the Canadian-headquartered company had roots in an auto-enrichment scheme Nick LabaMarch 23, 2020
Canada These scientists are crowdsourcing cannabis to find your perfect high Forget clinical studies, Cannametrics crunches user reviews to calculate how cannabinoids and terpenes will make you feel Michelle GamageMarch 19, 2020
International Allegations against PharmaCielo could tarnish promising Colombian industry Professor says claims about company with ‘brilliant’ strategy could hurt reputation of the country's other operators for some time Nick LabaMarch 11, 2020
International Cannabinoid CBM identified as potential treatment for type 2 diabetes Cannabimovone was shown to increase sensitivity to insulin Nick LabaMarch 6, 2020
Data Seniors’ rising cannabis use concerns NYU doctors The rate of use is up 75 % from 2015 to 2018, despite few studies being done to test how cannabis interacts with pharmaceutical... Michelle GamageFebruary 24, 2020